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A B S T R A C T
β-Lactoglobulin (β-Lg) is known to be capable to bind hydrophilic and hydrophobic bioactive compounds. This
research aimed to assess the in vitro performance of β-Lg micro- (diameter ranging from 200 to 300 nm) and nano
(diameter < 100 nm) structures associated to hydrophilic and hydrophobic model compounds on Caco-2 cells
and under simulated gastrointestinal (GI) conditions. Riboflavin and quercetin were studied as hydrophilic and
hydrophobic model compounds, respectively. Cytotoxicity experiment was conducted using in vitro cellular
model based on human colon carcinoma Caco-2 cells. Moreover, the digestion process was simulated using the
harmonized INFOGEST in vitro digestion model, where samples were taken at each phase of digestion process -
oral, gastric and intestinal - and characterized in terms of particle size, polydispersity index (PDI), surface charge
by dynamic light scattering (DLS); protein hydrolysis degree by 2,4,6-trinitrobenzene sulfonic acid (TNBSA)
assay and native polyacrylamide gel electrophoresis; and bioactive compound concentration. Caco-2 cell via-
bility was not affected up to 21 × 10−3 mg mL−1 of riboflavin and 16 × 10−3 mg mL−1 quercetin on β-Lg
micro- and nanostructures. In the oral phase, β-Lg structures’ particle size, PDI and surface charge values were
not changed comparing to the initial β-Lg structures (i.e., before being subjected to in vitro GI digestion). During
gastric digestion, β-Lg structures were resistant to proteolytic enzymes and to acid environment of the stomach –
confirmed by TNBSA and native gel electrophoresis. In vitro digestion results indicated that β-Lg micro- and
nanostructures protected both hydrophilic and hydrophobic compounds from gastric conditions and deliver
them to target site (i.e., intestinal phase). In addition, β-Lg structures were capable to enhance riboflavin and
quercetin bioaccessibility and bioavailability potential compared to bioactive compounds in their free form. This
study indicated that β-Lg micro- and nanostructures were capable to enhance hydrophilic and hydrophobic
compounds bioavailability potential and they can be used as oral delivery systems.
1. Introduction
The steady interest on the improvement of food quality and human
health led to a growing use of bioactive compounds level in food pro-
ducts (Chen, Zou, Liu, & McClements, 2016). Commonly, challenges
regarding to their inclusion in food products are attributed to the poor
solubility (e.g., hydrophobic compounds) in food matrices and their
instability along the digestion process (Bourbon, Pinheiro, Cerqueira, &
Vicente, 2018). Thus, to overcome these factors, designing of an ap-
propriate bio-based system to transport and deliver bioactive com-
pounds to a specific target site is of utmost importance (Gonçalves,
Martins, Duarte, Vicente, & Pinheiro, 2018).
β-lactoglobulin (β-Lg) is one the most abundant whey proteins (ca.
50 – 60 %) present in bovine serum (Samadarsi & Dutta, 2019). This
protein has nutritional and functional features (e.g., gelation capacity)
which allows the formation of structures with distinct properties and
morphologies (Ramos et al., 2012). These characteristics enable its use
as an oral vehicle system of bioactive compounds in food products
(Singh & Sarkar, 2011). Our previous results demonstrated that β-Lg
samples, purified from a commercial whey protein isolate through a
well-published method, exhibited a similar level of purity when com-
pared to a commercial β-Lg fraction, were able to form β-Lg micro-
(with diameters between of 200 and 300 nm) and nano (dia-
meters ≤ 100 nm) structures (Simões, Araújo, Vicente, & Ramos,
2020). Also, these structures successfully associated hydrophilic (i.e.,
riboflavin) and hydrophobic (i.e., quercetin) bioactive compounds, and
were able to maintain their stability, when subjected to various en-
vironmental conditions, and to release both bioactive compounds, in
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two food simulants with different hydrophobicities under different
temperatures (4 °C and 25 °C) (Simões, Abrunhosa, Vicente, & Ramos,
2020). Despite all these findings, more information is needed to un-
derstand the behaviour of β-Lg micro- and nanostructures with bioac-
tive compounds associated under gastrointestinal (GI) tract conditions.
Caco-2 cells derived from human colon adenocarcinoma gain a pro-
minence in in vitro assays because they mimic the absorption of the
bioactive compound across the epithelial membrane and they can be
used for toxicological assessment (Tibolla et al., 2019; Tibolla, Pelissari,
Martins, Vicente, & Menegalli, 2018). Moreover, β-Lg micro- and na-
nostructures need to assure bioactive compounds’ bioaccessibility in the
gastrointestinal (GI) tract to exert their bioactivity at a specific target
tissue (Rein et al., 2012). Therefore, in vitro digestion models (Pinheiro
et al., 2013; Pinheiro, Gonçalves, Madalena, & Vicente, 2017) were
used as a tool for understanding the influence of complex physico-
chemical and physiological processes on β-Lg bio-based structures and
on the release of bioactive compounds from those structures when they
pass through the different regions of the GI tract.
Few in vitro studies were found in the literature regarding β-Lg
structures associated with bioactive compounds. Madalena et al. (2016)
evaluated the effect of encapsulating riboflavin into β-Lg nanos-
tructures on riboflavin bioavailability upon a static in vitro GI digestion.
These authors concluded that β-Lg/riboflavin nanostructures act as a
vehicle for riboflavin until it reaches the intestine (i.e., target site),
where the protein degradation occurs. Moreover, they demonstrated
that 12 % of riboflavin recommended daily dose reached the intestine if
100 mL of a food simulant solution was ingested. Le Maux, Brodkorb,
Croguennec, and Hennessy (2013) investigated the potential changes in
β-Lg/linoleate complex after static in vitro digestion, as well as the li-
noleate acid bioaccessibility and their intracellular transport into Caco-
2 cells. These authors demonstrated that binding β-Lg to linoleic acid
influences the protein susceptibility to digestion. Also, β-Lg was capable
to modify linoleic acid transport and metabolism on Caco-2 cells. Al-
though these researches had underlined the importance of the in vitro
studies, there is limited information available regarding the in vitro si-
mulated mouth phase and the use of other bioactive compounds in such
structures. Moreover, information is very scarce or inexistent about the
potential effect of different β-Lg particle size structures – micro (dia-
meters between 200 and 300 nm) and nano (diameters ≤ 100 nm) – on
the bioavailability potential of bioactive compounds with different so-
lubilities. In this sense, the harmonized INFOGEST in vitro digestion
model was used in this study once which mimics the main in vivo
physiological digestion conditions (i.e., temperature, pH, ionic strength
and residence time), has a simple and standard methodology, and al-
lows the comparison with other researches who use the same proce-
dure. The present work intends to provides information about the po-
tential cytotoxicity on Caco-2 cell monolayer of β-Lg micro- and
nanostructures either isolated or associated to riboflavin and quercetin,
used as hydrophilic and hydrophobic, respectively, model compounds.
Bioaccessibility and bioavailability potential of both bioactive model
compounds were assessed when such compounds were associated to
and compared β-Lg micro- and nanostructures and compared when they
were present in their free form. Additionally, β-Lg micro- and nanos-
tructures hydrolysates during in vitro GI tract were evaluated. The final
intention is to provide useful information about the impact of β-Lg
micro- and nanostructures on the oral bioavailability of bioactive
compounds with distinct solubilities.
2. Materials and methods
2.1. Feedstocks and chemicals
The following chemicals were purchased from Sigma-Aldrich (St.
Louis, MO, USA): quercetin (≥ 95 %, HPLC), riboflavin (≥ 98 %,),
sodium azide, ANS (8-Anilino-1-napththalenesulfonic), sodium phos-
phate tribasic dodecahydrate 98 %, sodium dodecyl sulfate (SDS), tris
(hydroxymethyl)aminomethane, ammonium persulfate (APS),
Coomassie Brilliant Blue (R-250), bromophenol blue, etramethylethy-
lenediamine, pancreatin from porcine pancreas, pepsin from porcine
gastric mucosa, bile extract porcine, pefabloc® SC, 4-(2-aminoetyl)
benenesulfonyl fluoride, sodium and ammonium carbonate, potassium
phosphate dibasic, magnesium chloride, penicillin-streptomycin,
trypsin-EDTA solution (0.25 %), methylthiazolyldiphenyl-tetrazolium
(MTT) and celLytic™ MT cell lysis reagent. Acrylamide was purchased
from Bio-Rad (California, USA) and glycerol was obtained from
Himedia (Mumbai, India). Acetic and phosphoric acids, sodium hy-
droxide were purchased from Merck (Merck KGaA, Darmstadt,
Germany). Potassium and calcium chloride, hydrochloric acid, mono-
sodium phosphate, sodium chloride and glycine were obtained from
Panreac (Barcelona, Spain). Methanol and phosphate dibasic were
purchased from Chem-Lab (Zedelgem, Belgium) whereas dimethyl
sulfoxide was obtained from Fisher Scientific (New Hampshire, USA).
Serine was purchased from Acros Organics (Belgium) whereas TNBSA
(2,4,6-Trinitrobenzene Sulfonic Acid) was obtained from Thermo Fisher
Scientific (Bremen, Germany). Caco-2 cell line, obtained from human
colon carcinoma, was kindly supplied by Department of Biology of
University of Minho (Braga, Portugal). Dulbecco's Modified Eagle
Medium (DMEM) with L-glutamine, fetal bovine serum, non-essential
amino acids was purchased from Lonza (Basel, Switzerland). Hanks'
Balanced Salt solution (HBSS) was purchased from Biochrom GmbH
(Berlin, Germany) and others cell culture reagents were purchased from
Biowest (Nuaillé, France). All other chemicals used in this study were
reagent grade, and were used without further purification.
2.2. Development of β-Lg micro- and nanostructures
Food grade β-Lg micro- and nanostructures associated with bioac-
tive model compounds were prepared as described on Simões,
Abrunhosa, et al. (2020). Briefly, β-Lg powder at 5 and 15 mg mL−1
was used to develop nano- and microstructures, respectively, which was
solubilized in sodium phosphate buffer at pH 6. The pH values of so-
lutions were adjusted with 0.5 mol L−1 H3PO4 or 1 mol L−1 NaOH, as
necessary. β-Lg solutions were continuously stirred at 400 rpm during
2 h at room temperature (25 °C). Then, resulting solutions were stored
overnight at refrigeration temperature (5 °C) to enable a full protein
rehydration. The β-Lg solutions were filtered through a 0.2 µm mem-
brane filter (VWR International, USA) and subsequently, heated at 80 °C
for 15 min under continuously stirring on a temperature controlled
water bath (MR Hei-Tec + Pt 1000, Heidolph). After 15 min, a given
volume of model bioactive compounds was added to the β-Lg solutions.
Riboflavin (hydrophilic model compound), previously dissolved in
0.1 mol L−1 Na3PO4 and protected from light, was added to β-Lg so-
lution to obtain structures with final concentration of 0.105 mg mL−1
riboflavin. Quercetin (hydrophobic model compound) was solubilized
in ethanol and added to the β-Lg solutions to achieve 0.08 mg mL−1
quercetin concentration. Resulting solutions were cooled in ice for
10 min. According to our previous results (Simões, Abrunhosa, et al.,
2020), β-Lg/quercetin nanostructures formed precipitates after 2 days
of storage, independently of the storage temperature tested. β-Lg/ri-
boflavin micro- and nanostructures and β-Lg/quercetin microstructures
showed the best performance in terms of stability (Simões, Abrunhosa,
et al., 2020). For this reason, these structures were used on the sub-
sequent in vitro studies performed in this work. β-Lg micro- and na-
nostructures without associated bioactive compounds were used as
control samples.
2.3. β-Lg micro- and nanostructures effect on Caco-2 cells
The in vitro cellular model based on human colon carcinoma Caco-2
cells was applied to assess β-Lg structures cytotoxicity.
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2.3.1. Cell culture
Human colon carcinoma Caco-2 cell line was grown in DMEM
supplemented with 10 % heat inactivated fetal bovine serum, 1 % pe-
nicillin-streptomycin, 1 % L-glutamine and 1 % non-essential amino
acids. Caco-2 cell line was used between passages 60 – 68. Stocks cells
were maintained in culture flasks incubated at 37 °C with 5 % CO2
humidified atmosphere. Upon reaching approximately 90 % of con-
fluence, cells were harvested from culture flasks using trypsin-EDTA
(0.25 %). Viable cell number in suspension was carried out by counting
in a Neubauer chamber with an optical microscope (Tibolla et al.,
2018).
2.3.2. Cytotoxicity assay
Cytotoxicity test on Caco-2 cells were performed by MTT conversion
assay (Braz et al., 2017; Ren et al., 2018), according to Tibolla et al.
(2019) procedure. Briefly, β-Lg micro- (24 × 10−3 to 13.5 mg mL−1),
nanostructures (1 – 4.5 mg mL−1), β-Lg micro- and nanostructures
associated to riboflavin (21 × 10−3 to 94.5 × 10−3 mg mL−1 ribo-
flavin), β-Lg micro- and nanostructures associated to quercetin
(0.128 × 10−3 to 40 × 10−3 mg mL−1 quercetin), free bioactive
model compounds and ethanol (in equivalent quercetin concentrations)
were diluted in supplemented DMEM medium and homogenized. Caco-
2 cells suspension in supplemented DMEM medium were seeded at a
cell density of 4 × 104 cells/well in 96-well plate and incubated at
37 °C in 5 % CO2 atmosphere during 24 h. Cells only with DMEM was
used as control. Subsequently, DMEM medium was replaced by β-Lg
samples, free bioactive compounds and ethanol and maintained at 37 °C
in 5 % CO2 during 24 h. After incubation, the samples were removed
and cells were washed with PBS. Then, 100 μL MTT solution
(0.5 mg mL−1 in DMEM supplemented) was added into each well and
the plate was incubated at 37 °C for 4 h, in order to form soluble purple
formazan crystals. The crystals solubilization was performed by adding
200 μL of DMSO to each well followed by plate orbital shaken
(100 rpm) during 30 min. The purple formazan was quantified by
measurement of the absorbance at 570 nm and 690 nm (used for
background subtraction) in Synergy™ HT Multi-mode Microplate
Reader (Biotek Instruments, Winooski, VT, USA). The percentage of cell






where Asample is the absorbance value of sample with cell culture and
Acontrol is the absorbance value of DMEM with cell culture.
2.4. Gastrointestinal (GI) model
2.4.1. In vitro digestion
The in vitro digestion experiment was carried out using the harmo-
nized INFOGEST in vitro digestion model to mimic mouth, stomach, and
small intestine conditions as described by Minekus et al. (2014). Si-
mulated salivary fluid (SSF), simulated gastric fluid (SGF) and simu-
lated intestinal fluid (SIF) were the electrolyte stock solutions (ca.
1.25 × concentrated) used during in vitro digestion (Table 1).
Before in vitro digestion procedure, electrolyte stock solutions and β-
Lg micro- and nanostructures samples (5 mL) were inserted in a water
bath under constant shaking (37 °C, 120 horizontal strokes/min).
Initially, samples were exposed to simulated mouth conditions (SSF
solution) and CaCl2(H2O)2) (to achieve the concentration of 1.5 mmol
L−1 in fluid). Then, the final oral phase volume was adjusted with milli-
Q water and samples were returned to shaking water bath and in-
cubated at 37 °C for 2 min. Note that α-amylase was not used since the
samples do not contained starch. After oral phase, a sample was taken
and cooled in ice.
Subsequently, the passage through to stomach was mimicked by
adding porcine pepsin solution (with an activity of 2000 U mL−1 in the
final mixture), SGF solution and CaCl2(H2O)2 (to achieved 0.15 mmol
L−1 in the fluid). The pH value was adjusted to 3.0 with 1 mol L−1 HCl,
when necessary, and the gastric phase volume was complete with milli-
Q water. Samples were incubated at 37 °C during 2 h. After gastric
phase, a sample was taken and cooled in ice.
After 2 h, intestinal phase secretion composed by SIF solution,
CaCl2(H2O)2 (to achieved 0.6 mmol L−1 in the fluid,) pancreatin (with
an activity of 100 U mL−1 in the final mixture) and bile solutions (in
order to reach the concentration of 10 mmol L−1 in the final mixture)
(both prepared in SIF) were added to the gastric phase volume. The pH
value was adjusted to 7.0 with 1 mol L−1 NaOH, when necessary. The
final intestinal phase volume was adjusted with milli-Q water and then,
incubated under the same conditions as before for 2 h. In the end of
intestinal phase, the reaction was stopped by adding 1 mmol L−1 of
enzyme inhibitor pefabloc® SC.
During in vitro digestion samples were collected after each phase
(i.e., oral, gastric and intestinal) and cooled in ice before measure-
ments. Samples were tested in the in vitro digestion model at least in
triplicate.
2.4.2. Bioactive model compounds bioaccessibility and bioavailability
potential
Riboflavin and quercetin potential bioavailable fractions were as-
sessed using the method described by Pinheiro et al. (2013) with some
modifications. Briefly, intestinal phase samples of the β-Lg structures
(10 mL) were centrifuged (Allegra 64R, Beckman Coulter, USA) at 18
000 g during 30 min at 25 °C. Following centrifugation, samples were
separated in two distinct phases, being at bottom an opaque sediment
phase and at the top a clear micelle phase. It was assumed that the
model bioactive compounds were in the clear micelle phase (i.e., the
bioaccessible fraction) which was available to be absorbed and meta-
bolic processed (Silva et al., 2018). Then, aliquots (5 mL) of micelle
phase (supernatant) were collected and used to quantify the amount of
bioactive compound released after in vitro digestion. Riboflavin con-
centration was determined by fluorescence spectroscopy according to
the methodology described in Section 2.8.1. Fluorescence intensity was
corrected by blank fluorescence subtraction (i.e., in vitro digestion
without β-Lg/riboflavin micro- and nanostructures). Quercetin quanti-
fication was determined by high performance liquid chromatography
with fluorescence detection (HPLC-FL). Briefly, quercetin samples were
diluted in DMSO and centrifuged (Mikro 120, Andreas Hettich GmbH &
Co.KG, Tuttlingen, Germany) at 13 000 g during 10 min at 25 °C. The
supernatant was dissolved in methanol to precipitate the protein and
centrifuged again at same conditions. Then, resulting sample was fil-
tered through a 0.22 µm nylon filter before analysis described in
Section 2.8.2. Riboflavin and quercetin bioaccessibility (Eq. (2)), and
bioavailability potential (Eq. (3)) were determined as reported by Liu,






Composition of simulated salivary fluid (SSF), simulated gastric fluid (SGF) and
simulated intestinal fluid (SIF) stock solutions.
SSF (mmol L−1) SGF (mmol L−1) SIF (mmol L−1)
KCl 15.10 6.90 6.80
KH2PO4 3.70 0.90 0.80
NaHCO3 13.60 25.00 85.00
MgCl2(H2O)6 0.15 0.12 0.33
(NH4)2CO3 0.06 0.50 –
NaCl – 47.20 38.40
HCl – 15.60 8.40
NOTE: CaCl2(H2O)2 was added to the final of each fluid mixture of digestion to
avoid precipitation.


















where CMicellePhase is the concentration of bioactive model compounds in
the micelle phase, CIntestinalPhase is the concentration of bioactive model
compounds after in vitro digestion, and CInitial was the initial model
bioactive compounds concentration added into the β-Lg structures.
2.5. Monitoring protein hydrolysis degree during in vitro digestion
In order to evaluate β-Lg micro- and nanostructures hydrolysis de-
gree (HD) during in vitro digestion, TNBSA assay was performed ac-
cording to Castillo, Mendez, Al-Azzam, Barletta, and Griebenow (2006).
A sample (0.5 mL) of each in vitro digestion phase was diluted directly
in 0.1 mol L−1 bicarbonate buffer at pH 8.5 to achieve final protein
concentration between 0.05 and 0.2 mg mL−1. Subsequently, 0.25 mL
of 0.1 % TBNSA was added to the resulting solution (0.5 mL) and in-
cubated at 37 °C during 2 h. Then, 0.25 mL of 10 % SDS and 1 mol L−1
HCl was added to each sample and homogenized. Considering the po-
tential interference of the pepsin from the gastric juice and pancreatin
from intestinal phase, in vitro digestion without sample was used as
blank. Sample absorbance measurements were carried out at 335 nm in
Synergy™ HT Multi-mode Microplate Reader (Biotek Instruments, Wi-
nooski, VT, USA). All samples were analysed in triplicate and the amino
group content was performed by reference serine standard curve
( = + =y x R0.0207 0.0236; 0.992 ; being y and x the absorbance and
concentration of serine, respectively). The HD was referred according to
the percentage of peptide bond cleaved in the total number of peptide






where hsample is the number of peptide bonds cleaved in sample after
each in vitro gastrointestinal phase and htotal is the total number of
peptide bond after intestinal phase.
2.6. Native polyacrylamide gel electrophoresis (Native–PAGE)
Native-PAGE or “non-denaturing” gel electrophoresis was per-
formed to evaluate β-Lg structures integrity during in vitro digestion.
The electrophoresis analysis was carried out using Mini-Protean II dual
slab cell system equipped with a PAC 300 power supply (Bio-Rad
Laboratories, Hercules, CA, USA), according to Madalena et al. (2016)
methodology. The resolving and stacking gel contained 12.5 % and 3.5
% of polyacrylamide, respectively. The gels were stained and main-
tained in Coomassie Brilliant Blue (R-250) solution, composed by 50 %
methanol and 10 % acid acetic, and maintained overnight with gentle
agitation. Afterwards, gels were destained with solution constituted by
30 % methanol and 7 % acetic acid. Standard marker protein PageRuler
Unstained Broad Range Protein Ladder (Thermo Scientific) was used to
identify samples by their molecular weight.
2.7. Particle size, polydispersity index and surface charge measurements
Particles size, polydispersity index (PDI) and surface charge (S) of β-
Lg micro- and nanostructures dispersions were performed by DLS
(Zetasizer Nano ZS, Malvern Instruments, UK) equipped with He-Ne
laser at a wavelength of 633 nm, at 25 °C. The intestinal phase of in vitro
digestion was diluted prior to analysis at a ratio of 1:50 (v/v) in milli-Q
water to avoid multiple scattering effects. All samples measurements
were performed at least in triplicate with nine successive measure-
ments. The results were reported as the mean ± standard deviation.
2.8. Determination of bioactive model compounds concentration
2.8.1. Riboflavin – hydrophilic model compound
The riboflavin concentration was evaluated by fluorescence mea-
surement using microplate reader with excitation wavelength at
450 nm and emission wavelength at 530 nm (BioTekTM CytationTM 3,
USA). The emission wavelength corresponded to the maximum fluor-
escence intensity of riboflavin. Standard solutions of riboflavin were
used to establish an appropriate calibration curve
( = + =y x R60, 293 143.8; 0.99;2 wherey and x were the fluorescence
and riboflavin concentration, respectively).
2.8.2. Quercetin – hydrophobic model compound
Quercetin concentration was conducted by high performance liquid
chromatography with fluorescence detection (HPLC-FL). The HPLC
system used consisted of a Varian Prostar 210 pump, a Varian Prostar
410 autosampler, and a Jasco FP-920 detector. The column used was a
C18 column reversed-phase YMC-Pack ODS (4.6 × 250 mm i.d; 5 μm
particle size). The mobile phase was composed of acetonitrile and dis-
tillate water (40:60, v/v), and was pumped at a flow rate of
1.0 mL min−1. The wavelengths used for quercetin detection were
355 nm (excitation) and 525 nm (emission) (Komori, Inoue, Fujita,
Kasajima, & Horii, 2007). Quantification was determined according to
the standard curve of peak area versus quercetin concentration (ranging
from 0 to 0.10 mg mL−1) with a correlation coefficient of 0.99.
2.9. Statistical procedures
All experiments were carried out at least in triplicate and data were
expressed as the average ± standard deviation (SD). The statistical
analysis was performed by One-way analysis variance (ANOVA) cou-
pled with Tukey post-hoc test with a significance level of 5 %
(p ≤ 0.05) using Statistica package software version 10.0.228.8
(StatSoft Inc., Tulsa, OK, USA).
3. Results and discussion
3.1. β-Lg micro- and nanostructures effect on cell viability
It is important to assess riboflavin and quercetin cytotoxicity once
the presence of toxic substances may causes damage to cells and leads
to losses in the efficiency of bioactive compounds absorption loss
(Sedaghat Doost et al., 2019). However, it was reported that bile salts
compounds (i.e., glycine and taurine conjugates of cholic acid or
deoxycholic acid sodium salt mixtures) may be toxic to cells, leading to
DNA damage (Benedetti et al., 1997; Yi, Zhong, Zhang, Yokoyama, &
Zhao, 2015). In this sense, the potential cytotoxicity of initial (i.e.,
before in vitro digestion) of β-Lg micro- and nanostructure samples with
and without riboflavin and quercetin were evaluated on Caco-2 cells
after 24 h of exposure (Fig. 1).
Fig. 1A showed the potential adverse effect of β-Lg micro- and na-
nostructures with or without riboflavin and free riboflavin on Caco-2
cells. Overall, the cell viability decreased as the exposure concentration
increased (p ≤ 0.05). According to the literature, β-Lg is a Generally
Recognized As Safe (GRAS) bio-based material (Ramos et al., 2017;
Tavares, Ramos, & Malcata, 2017) ( and riboflavin is an essential
compound for the human body (Madadlou, Floury, Pezennec, &
Dupont, 2018; Madalena et al., 2016; O’Neill et al., 2015). Thus, the
adverse effect of such structures could be related to their concentration.
Caco-2 cell exposure to increased riboflavin and quercetin concentra-
tions presumably indicated an enhance compounds cellular uptake
leading to lysosomes saturation, DNA cells impairment and injured
membrane (Tibolla et al., 2018).
β-Lg microstructures without bioactive compounds showed a cell
viability between 25.6 and 82.0 %, whereas β-Lg nanostructures’ de-
monstrated a cell viability of ca. 39.5 to 58.5 % (p ≤ 0.05) (for
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riboflavin equivalent concentration ranging from 31.5 to 94.5 × 10−3
mg mL−1) (Fig. 1A). Possibly, the particles' size may have an adverse
effect on the cellular uptake of β-Lg structures in Caco-2 cells. Struc-
tures at nanoscale have a large surface area per unit, which can possibly
increase the adherence and interaction with cell membranes, leading to
an enhanced cellular uptake of nanostructures (Ha, Kim, Lee, Jun, &
Lee, 2015; Quintanilla-Carvajal et al., 2010), and consequently, to a
higher cell cytotoxicity.
On the other hand, cytotoxicity results revealed that β-Lg/riboflavin
micro- and nanostructures at equivalent concentrations ranging from
52.5 to 73.5 × 10−3 mg mL−1 of riboflavin did not significantly de-
crease Caco-2 cell viability as compared to the control group (ca. 100 %
cell viability) (p > 0.05). This behaviour may be attributed to ribo-
flavin protective effect against the possible toxicity caused by β-Lg
micro- and nanostructures, since the result of the interaction between β-
Lg and riboflavin may generate reactive radical and oxygen species
(Diarrassouba, Liang, Remondetto, & Subirade, 2013a). β-Lg micro- and
nanostructures with riboflavin associated (Fig. 1A) at concentration of
21 × 10−3 mg mL−1 showed cell viabilities higher than 90 % for all
samples tested. This result (21 × 10−3 mg mL−1 riboflavin) indicated
that β-Lg/riboflavin microstructures (12.8 × 10−3 mg mL−1 β-Lg mi-
crostructures) and β-Lg/riboflavin nanostructures (16.9 × 10−3 mg
mL−1 β-Lg nanostructures) did not cause damage to cells.
Regarding quercetin cell viability (Fig. 1B), all samples tested
showed 100 % cell viability until 16 × 10−3 mg mL−1 of quercetin.
However, increased concentrations up to 40 × 10−3 mg mL−1 of β-Lg
microstructures, without quercetin, reduced the cell viability to 73.1 %,
which demonstrated an adverse effect comparing to the control group
(p ≤ 0.05). Martirosyan, Grintzalis, Polet, Laloux, and Schneider
(2016) reported that silver nanoparticles (particle size < 20 nm) re-
duced the Caco-2 cell viability, promoting the generation of ROS and
reactive nitrogen species (RSN). Nevertheless, 50 μmol L−1 of quercetin
was able to protect cells against oxidative stress and/or inflammatory
activities. Due to quercetin hydrophobic nature, absolute ethanol is
often used to previously dissolve it (Al-Shabib et al., 2019). Then, a
determined amount of quercetin stock solution was used to form β-Lg/
quercetin microstructures. However, the organic solvent concentration
used and cell exposure time could cause a toxic effect on Caco-2 cells
(Tseng et al., 2006). Fig. 1B shows that ethanol at all concentrations
tested (ethanol at equivalent concentration ranging of 0.128 to
40 × 10−3 mg mL−1 of quercetin) did not produced cytotoxicity to the
cells compared to the control group (p > 0.05). From Fig. 1B, cell
viability above 100 % was observed for free quercetin in all con-
centrations tested. Works reported in literature shows that cytotoxicity
is narrowly associated with the oxidative stress in cells (Wang et al.,
2014a) and as quercetin and its cellular metabolites have antioxidant
properties, this compound is able to promote ROS scavenging due to
cellular stress (Gonzales et al., 2016). Similar behaviour for other hy-
drophobic bioactive compound were reported by Le Maux, Giblin,
Croguennec, Bouhallab, and Brodkorb (2012). These authors in-
vestigated the in vitro cytotoxicity on intestinal epithelial cells of β-Lg as
a vehicle of linoleate. They demonstrated an enhanced cell viability
compared to the control group at low free bioactive compound con-
centrations (ranging from 5 to 25 μmol L−1).
3.2. Evaluation of β-Lg micro- and nanostructures responsiveness along in
vitro digestion process
In order to evaluate the structural properties of β-Lg micro- and
nanostructures during in vitro digestion, initial samples (i.e., before in
vitro digestion) and samples collected in each digestion phase (i.e., oral,
gastric and intestinal) were analysed in terms of particle size, PDI and
surface charge by DLS (Table 2).
β-Lg microstructures’ initial samples exhibited an average particle
size ranging from 205.3 ± 3.8 to 235.7 ± 7.8 nm. whereas β-Lg
nanostructures initial samples showed average particle sizes between
58.0 ± 1.7 and 79.4 ± 2.2 nm (Table 2). PDI values demonstrated
that these structures were homogenous with a narrow size distribution
(PDI < 0.25).
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Fig. 1. Caco-2 cell viability in contact to
β-Lg/riboflavin micro- and nano-struc-
tures (A) and β-Lg/quercetin micro-struc-
tures (B) after 24 h incubation (bars re-
present standard deviation). a,b,c,d Values
with different letter superscripts for the
same compound concentration were sta-
tistically different (p ≤ 0.05). The asterisk
(*) indicates significant difference
(p ≤ 0.05) relative to the control.
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nanostructures size and PDI values remained similar to the values of
initial samples (p > 0.05), indicating that β-Lg structures were stable
and maintained the initial characteristics under simulated oral phase
with salivary fluids. The surface charge values suggested that electro-
static repulsion among the particles was sufficiently high enough to
prevent aggregation. Taking in consideration the β-Lg micro- and na-
nostructures as a potential oral delivery system, it is crucial to guar-
antee the protein structural properties until reaching the intestine
(McClements, 2015).
After β-Lg micro- and nanostructures pass from the simulated oral to
gastric phase (Table 2), an increase of particles’ size was observed
(p ≤ 0.05), suggesting that β-Lg structures at simulated gastric phase
tend to agglomerate. These changes were accompanied by β-Lg struc-
tures instability, due to surface charge close to 0 mV, and hetero-
geneity, characterized by high PDI values (> 0.34) (Table 2). Indeed,
the stomach environment is characterized by high acidity (i.e., pH value
ranging from 1 to 3) and ionic strength (values around 100 mmol L−1)
(Gonçalves et al., 2018). Considering that β-Lg micro- and nanos-
tructures samples were initially at pH 6 and their isoelectric point (pI) is
near pH 4.8, this could explain the results obtained in the gastric phase.
The transition to gastric phase might promote changes in the interfacial
composition leading to β-Lg micro- and nanostructures aggregation.
Madalena et al. (2016) described that β-Lg/riboflavin nanostructures
particle size increased (from 232 ± 21 nm to 329 ± 23 nm) after
simulated gastric phase. The presence of intact β-Lg structure in the
stomach was depicted by Li, Cui, Ngadi, and Ma (2015). These authors
performed an in vitro gastrointestinal digestion of β-Lg/curcumin
complex in simulated gastric fluid (SGF). The authors monitored the
protein behaviour using SDS-PAGE and reported that the β-Lg band did
not exhibit any reduction intensity in SGF after 90 min of digestion.
Results from the intestinal phase showed that surface charge of β-Lg
micro- and nanostructures decreased to approximately –22 mV
(Table 2), which were very similar to surface charge values of the β-Lg
structure samples before in vitro digestion. This behaviour can be at-
tributed to pH changing to 7 in intestinal phase and/or due adsorption
of bile salts and electrolytes on sample surface (Hur, Decker, &
McClements, 2009; Pinheiro et al., 2013). Comparing to gastric phase
digestion, it was observed a decrease of β-Lg micro- and nanostructures’
particle sizes (p ≤ 0.05) in simulated intestinal phase; however, sam-
ples remained heterogeneous (PDI > 0.72). These large particles sizes
were due to precipitates formed during in vitro digestion. These
precipitates production could be due to aggregation or flocculation
provoked by digestive enzymes action or to changes in pH and ionic
strength (Bourbon, Pinheiro, Cerqueira, & Vicente, 2016; Pinheiro
et al., 2013).
β-Lg micro- and nanostructures with and without a bioactive model
compounds associated revealed similar behaviour for particle size, PDI
and surface charge. The structural properties of β-Lg micro- and nano-
structures, during in vitro digestion process, were further characterized
by native-PAGE and primary amine groups determination.
3.2.1. β-Lg micro- and nanostructures hydrolysis degree during in vitro
digestion
In order to predict the extent of β-Lg micro- and nanostructures
hydrolysis during in vitro digestion, the TNBSA assay was performed to
determine the number of peptide bonds cleaved (Fig. 2).
The TNBSA method determines the amount of primary amine mo-
lecules in the system (Spellman, McEvoy, O’Cuinn, & FitzGerald, 2003).
As the peptide bonds of β-Lg structures were cleaving during in vitro
digestion, the number of free amino groups increased and consequently,
the hydrolysis degree (HD) increased.
The TNBSA results (Fig. 2) revealed that HD of the initial samples
(i.e., before in vitro digestion) and of the samples under simulated oral
phase were maintained at values lower than 8.3 %. In both conditions,
no statically significant differences (p > 0.05) were observed, in-
dependently of β-Lg structures studied. Additionally, the HD profile
observed for β-Lg micro- and nanostructures in initial and oral phases
was very similar to the ones observed to β-Lg micro- and nanostructures
with associated bioactive compounds. This behaviour was consistent
with DLS data (Table 2), which showed that particle size, PDI and
surface charge were maintained in initial and oral phases.
Subsequently, after 2 h under gastric phase, it was obtained a slight
enhance of β-Lg structures HD to a maximum of 19.5 % (p ≤ 0.05).
Generally, food proteins are usually hydrolysed in the stomach en-
vironment (Zhang & Vardhanabhuti, 2014). Bourbon et al. (2018)
evaluated both lactoferrin (Lf) and glycomacropeptide (GMP) nanohy-
drogels hydrolysis using an in vitro dynamic GI model. These authors
observed that at least 45 % of Lf and 70 % of GMP remain undigested
after simulated gastric phase. Our results demonstrated that 80.5 % of
β-Lg micro- and nanostructures remained almost intact. β-Lg is highly
resistant to proteolytic enzymes and pH conditions of the stomach due
to its stable globular tertiary structure at low pH (i.e., pH < 3) (Ramos
Table 2
Particle size, polydispersity index (PDI) and surface charge (S) of β-Lg micro- and nanostructures in each in vitro digestion phase.
Structure In vitro digestion phase Particle size (nm) PDI S (mV)
β-Lg micro Initial 235.7 ± 7.8a 0.14 ± 0.06a −19.7 ± 2.1a
Oral 226.0 ± 8.6a 0.20 ± 0.03a −21.6 ± 0.8a
Gastric 3853.7 ± 509.7b 0.34 ± 0.14ab 1.0 ± 0.2b
Intestinal 529.1 ± 44.0c 0.43 ± 0.12b −24.3 ± 0.6c
β-Lg/riboflavin micro Initial 205.3 ± 3.8a 0.23 ± 0.03a −21.8 ± 1.6a
Oral 193.2 ± 6.6a 0.27 ± 0.06a –23.8 ± 1.4a
Gastric 2655.7 ± 362.8b 0.53 ± 0.08b 11.1 ± 0.4b
Intestinal 547.1 ± 40.7c 0.72 ± 0.11c –23.2 ± 0.5a
β-Lg/quercetin micro Initial 224.4 ± 6.4a 0.18 ± 0.03a −18.5 ± 1.1a
Oral 210.7 ± 3.2a 0.17 ± 0.03a −21.0 ± 1.1b
Gastric 3136.9 ± 220.1b 0.69 ± 0.16b 2.0 ± 0.4c
Intestinal 538.6 ± 30.8c 0.46 ± 0.15c −21.4 ± 0.6b
β-Lg nano Initial 58.0 ± 1.7a 0.24 ± 0.01a −16.8 ± 1.0a
Oral 66.6 ± 2.8a 0.37 ± 0.02a −16.9 ± 2.2a
Gastric 1291.7 ± 136.1b 0.78 ± 0.09b −1.5 ± 0.3b
Intestinal 582.4 ± 39.9c 0.63 ± 0.12c –22.6 ± 0.9c
β-Lg/riboflavin nano Initial 79.4 ± 2.2a 0.23 ± 0.01a −16.5 ± 0.3a
Oral 79.5 ± 2.7a 0.25 ± 0.01a −16.2 ± 2.2a
Gastric 4017.5 ± 497.6b 0.97 ± 0.05b 0.9 ± 0.5b
Intestinal 600.8 ± 44.8c 0.66 ± 0.06c −24.3 ± 0.6c
a,b,c Different superscript letters indicate statistical difference in the same column for the same β-Lg structure between in vitro digestion phase mean values
(p ≤ 0.05).
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et al., 2017). Pepsin is the major enzyme present in the gastric fluid and
it has been reported that this enzyme has broad specificity with a
preference for hydrophobic residues (Luo et al., 2015; Zhang &
Vardhanabhuti, 2014). Nonetheless, the highly hydrophobic β-barrel
present inside the β-Lg structure hampers pepsin to access target pep-
tide bonds (Bateman, Ye, & Singh, 2010). These features are essential to
maintain the protein stability until reaching the delivery target
(Madalena et al., 2016).
After β-Lg micro- and nanostructures having been exposed to si-
mulated intestinal conditions, the HD reached 100 % (Fig. 2), indicating
a complete hydrolysis of the β-Lg structures. This result can be attrib-
uted to the proteolytic action of pancreatin, which digested β-Lg micro-
and nanostructures into smaller peptides (Mantovani, Pinheiro,
Vicente, & Cunha, 2017). These results are in agreement with others
authors. Guo, Harris, Kaur, Pastrana, and Jauregi (2017) produced β-Lg
nanoparticles for caffeine encapsulation and evaluated their behaviour
upon in vitro digestion. The authors observed that caffeine remained
entrapped in β-Lg nanoparticles under the harsh stomach environment.
However, a total release of the bioactive compound was achieved in
intestinal conditions. Mandalari et al. (2009) proposed a work on a β-Lg
in vitro digestion under simulated human gastric and duodenal condi-
tions focused on the digestibility of protein. They reported that β-Lg
resists to physiological gastric digestion, being susceptible to degrada-
tion during duodenal digestion. Another interesting approach based on
in vivo studies using force-fed rats was assessed by Diarrassouba et al.
(2015) to enhance the bioavailability of vitamin D3 associated with β-
Lg nanoparticles. The authors demonstrated that β-Lg nanoparticles
were degraded and the bioactive compound released in the rat intes-
tine.
To further explore the β-Lg micro- and nanostructures hydrolysis, a
native-PAGE electrophoresis was carried out.
3.2.2. Native polyacrylamide gel electrophoresis (Native-PAGE)
Native-PAGE electrophoresis is a complementary technique used to
provide new insights on β-Lg structures hydrolysis during in vitro di-
gestion. Fig. 3 shows Native-PAGE series with sample band patterns,
which allowed a better elucidation on the β-Lg structures hydrolysis as
function of the different in vitro digestion phases.
Gel electrophoresis is a technique for separation and analysis of
macromolecules (e.g., proteins) and their fragments according to their
molecular weight (Mw) (Arndt, Koristka, Bartsch, & Bachmann, 2012).
Since pancreatin and pepsin are digestive enzymes (i.e., proteins)
(Sullivan, Pangloli, & Dia, 2018) used during in vitro digestion it was
crucial to identify their Mw, as control samples. Native-PAGE results in
Fig. 3A showed an in vitro digestion without samples (lane 1), pan-
creatin (lane 2) and pepsin (lane 3) profiles. Pancreatin is a mixture of
several enzymes, for instance trypsin, amylase and lipase, secreted by
the exocrine cells of pigs pancreas (Picariello et al., 2015). Pancreatin
sample (lane 2) showed Mw bands corresponding to trypsin
(Mw = 20 kDa), amylase (Mw = 45 kDa) and lipase (Mw = 38 kDa)
(Shen, Liu, Lee, & Chen, 2013). Moreover, pepsin (lane 3) was char-
acterized by the presence of a single band with Mw of 30 kDa. These
results are in agreement with Peram, Loveday, Ye, and Singh (2013)
results. These authors evaluated heat-induced β-Lg aggregates upon in
vitro gastric digestion by native-PAGE electrophoresis and they ob-
tained a Mw = 37 kDa for pepsin. Thus, the bands identified in lanes 2
and 3 were presented in lane 1, which correspond to the final sample
taken from the in vitro digestion process.
β-Lg structures (with or without bioactive compounds) before in
vitro digestion revealed similar electrophoretic profiles, showing the
major Mw band with values ranging from 15 to 20 kDa (Fig. 3B−F, lane
4). This band was attributed to β-Lg because its Mw is 18.4 kDa (Zagury,
Kazir, & Livney, 2019). It was also observed the presence of a high Mw
band which could be related to protein aggregates formed during ge-
lation treatment. These results were consistent with those reported
elsewhere (Madalena et al., 2016; Rodrigues et al., 2015).
The electrophoretic profile of β-Lg micro- and nanostructures upon
oral phase and gastric phase showed two predominant bands with Mw
ranging from 15 to 20 kDa (Fig. 3B–E, lanes 5 and 6). These results
suggested that β-Lg micro- and nano-structures remained almost intact
until the gastric phase – in agreement with the results obtained in
TNBSA test. Moreover, the band corresponding to the β-Lg
(Mw = 18 kDa) was not detected in β-Lg/riboflavin nanostructures’
samples after gastric phase (Fig. 3F, lane 6). Nevertheless, Madalena
et al. (2016) studied β-Lg/riboflavin nanostructures throughout diges-
tion, simulating the physiological conditions in the stomach and small
intestine using an in vitro static GI system. The authors performed a
native-PAGE electrophoresis for each in vitro digestion phase and ob-
tained a Mw band corresponding to β-Lg after being submitted to gastric
conditions. Taking into consideration the results obtained, including
HD data of β-Lg/riboflavin nanostructures, it can be suggested that β-Lg
micro- and nanostructures are highly resistant to stomach environment
conditions.
Similar electrophoresis profiles were observed comparing β-Lg
micro- and nanostructures upon passage by the intestinal phase
(Fig. 3B–F, lane 7). The band attributed to β-Lg with Mw ranging from
15 to 20 kDa was not observed, suggesting the β-Lg micro- and na-
nostructures degradation, which is in accordance with protein hydro-
lysis data of intestinal phase samples (Fig. 2). Despite the resistance of
β-Lg, it was more susceptible to pancreatin degradation (Lassé et al.,
2016). β-Lg degradation under intestinal conditions was also reported
by Zagury et al. (2019) who conducted a study with β-Lg system to
a a a a a a a a a a 
b b b b b 
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Fig. 2. Hydrolysis degree (%) of βLg-micro and nanostructures with (or without) bioactive riboflavin (rib.) and quercetin (quer.) model compounds during in vitro
digestion. a,b,c Small superscript letters in each column indicate statistical difference between means (p ≤ 0.05) for the same β-Lg structure.
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enhance the in vitro bioaccesibility of (-)-epigallocatechin-3-gallate. For
this purpose, the authors performed a simulated GI digestion of the β-
Lg/(-)-epigallocatechin-3-gallate system and obtained β-Lg resistance in
simulate gastric conditions and a complete degradation under intestinal
environment. Diarrassouba et al. (2013b) studied the pH-stability of the
β-Lg/vitamin D3 complex to evaluate the potential impact on the sta-
bility of such structures through the GI tract. The authors concluded
that β-Lg/D3 complex remained stable under acidic (pH ranging from
3.0 to 4.0) and alkaline (pH ranging from 6.8 to 8.0) environments,
suggesting that this complex could be pH stable along the digestion
process.
3.3. Bioactive model compounds behaviour under gastrointestinal
environmental conditions
Throughout in vitro GI digestion, β-Lg micro- and nanostructures
were subjected to several conditions, such as pH changes and enzymatic
action. These factors could affect the capacity of such structures to
protect bioactive compounds. Therefore, the amounts of intact ribo-
flavin and quercetin in oral, gastric and intestinal phases were assessed
(Fig. 4).
Fig. 4A shows the intact riboflavin in free form (%) during in vitro
digestion. Free riboflavin (Fig. 4A) results showed that only 28.7 ± 0.4
% of their initial concentration (i.e., 0.105 mg mL−1) reached the
A B 
C D 
 E F 
      M            1          2         3  M             4      5         6        7 
M          4       5       6        7 M           4       5      6       7 
M            4       5      6      7 M             4      5      6      7
Fig. 3. Native-PAGE of in vitro digestion samples: control (A); β-Lg microstructures (B); β-Lg microstructures with riboflavin (C); β-Lg microstructures with quercetin
(D); β-Lg nanostructures (E); and β-Lg nanostructures with riboflavin (F). The lanes represent: commercial molecular weight marker (M) intestinal phase of in vitro
digestion without sample (1); pancreatin from porcine pancreas (2); pepsin from porcine gastric mucous (3); initial β-Lg structures (before in vitro digestion) (4); oral
phase (5); gastric phase (6) and intestinal phase (7).
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intestinal phase; thus, it is crucial to use β-Lg structures to protect them
from chemical and enzymatic degradation.
On the first phase of digestion (i.e., oral phase with simulated
salivary fluid), it was observed a decrease (p ≤ 0.05) of free riboflavin
concentration of ca. 3 % (to 96.6 ± 2.0 %) compared with β-Lg/ri-
boflavin micro- (106.0 ± 5.5 %) and nano (104.9 ± 2.6 %) struc-
tures. The harmonized INFOGEST in vitro model mimics the oral phase,
which is constituted by a neutral environment (i.e., pH 7) and an
electrolyte solution (SSF) (Minekus et al., 2014). The presence of ions in
the SSF did not affect the β-Lg micro- and nanostructure properties
(Table 2), which might delay the riboflavin degradation in the oral
phase, when compared to the free form.
In the gastric phase (Fig. 4A), 81.2 ± 1.7 % of riboflavin from β-
Lg/riboflavin microstructure samples were intact. This result was si-
milar (p > 0.05) to that obtained for free riboflavin. However, the
percentage of intact riboflavin from β-Lg/riboflavin nanostructures was
significantly different (p ≤ 0.05) from those obtained for riboflavin in
free form or for β-Lg/riboflavin microstructures. This behaviour sug-
gests that β-Lg nanostructures were able to better protect riboflavin
from degradation at gastric phase than β-Lg microstructures. Intestinal
phase results (Fig. 4A) shown that β-Lg microstructures were able to
retain 53.2 ± 0.9 % of intact riboflavin until absorption, whereas β-Lg
nanostructures maintained 61.7 ± 4.1 % of intact riboflavin
(p ≤ 0.05). The information obtained in this study was consistent with
results observed by Maltais, Remondetto, and Subirade (2010). The
authors investigated a soy protein filamentous hydrogel for riboflavin
release under simulated GI conditions. They observed in simulated
gastric fluid with pepsin, that 13 % of total riboflavin was released from
hydrogel. It was argued that the low riboflavin release in gastric con-
ditions was due to the soy hydrogel resistance to pepsin. The pepsin
resistance was attributed to a low amount of hydrophobic aromatic
amino acids available in soy protein hydrogel, which are the pre-
ferential cleavage sites of pepsin in proteins. Moreover, the pancreatin
in intestinal phase led to the thorough soy protein filamentous hydro-
gels degradation and 100 % release of initial riboflavin concentration
used.
Quercetin content in each in vitro digestion phase was also studied
(Fig. 4B). Free quercetin started to be degraded after exposure to si-
mulated oral phase conditions, being the level of intact quercetin of
65.0 ± 3.5 % in relation to the initial quercetin concentration (i.e.,
0.8 mg mL−1). The content of free quercetin content was maintained in
the gastric phase, being, however, not detected in the intestinal phase
(Fig. 4B). These results demonstrated that quercetin needs to be pro-
tected from physiological GI tract conditions, since this hydrophobic
bioactive compound has a poor solubility, rapid metabolism and low
absorption (Chen, Zou, Liu, & McClements, 2016). Quercetin has poor
water solubility (Wang et al., 2014b), and requires prior solubilization
in an organic solvent, in this case, ethanol. When this ethanolic solution
is added in the aqueous system, large precipitates were formed, dis-
playing an atypical needle-like morphology, which is extremely un-
stable (Patel, Heussen, Hazekamp, Drost, & Velikov, 2012). Moreover,
quercetin also has a low solubility in simulated gastric (5.5 μg mL−1)
and intestinal (28.9 μg mL−1) fluids (Gao et al., 2009), which increase
the formation of precipitates when quercetin is present in its free form.
When quercetin is associated with β-Lg microstructures (Fig. 4B), it was
observed an increase of the content of intact quercetin along the various
phases of in vitro digestion (p ≤ 0.05). The content of intact quercetin
increased in oral and gastric phases being 96.2 ± 2.5 % and
100.5 ± 1.5 %, respectively, and decreased in the intestinal phase to
5.3 ± 0.5 %. This behaviour may be attributed to the fact that quer-
cetin molecules were protected by the β-Lg microstructures from the
surrounding aqueous phase (Chen et al., 2018), avoiding their de-
gradation. Fang et al. (2011) developed bovine serum album nano-
particles to encapsulate quercetin and reported that the system could
maintain quercetin bioactive properties under both neutral and acidic
environments.
3.3.1. Bioactive model compounds bioaccessibility and bioavailability
In the reports found in the literature regarding the food applica-
tions, studies about the determination of bioaccessibility and bioavail-
ability of bioactive compounds are still limited. In this sense, the eva-
luation of riboflavin and quercetin bioaccessibility and bioavailability
potential was conducted to fill this gap (Fig. 5).
Bioaccessibility is related with the fraction of bioactive compound
released from the structure and potentially available for absorption
(Gonçalves et al., 2018). The riboflavin bioaccessibility results (Fig. 5A)
revealed that 100 % of riboflavin in free form and β-Lg/riboflavin
micro- and nanostructures that reach the intestinal phase can be po-
tentially absorbed. This can be due to the water solubility properties of
riboflavin that may facilitate a higher passage through the various si-
mulated GI phases. Regarding quercetin bioaccessibility results
(Fig. 5B), this bioactive compound in free form was not capable to reach
to intestinal phase and be bioaccessible, which may be attributed to the
low solubility of quercetin in simulated intestinal fluid (Chen et al.,
2018).
The bioaccessibility of quercetin in free form in bulk water was
reported to be low (< 5 %) when tested at 0.1 and 0.5 mg mL−1 (Pool,
Mendoza, Xiao, & McClements, 2013). Nevertheless, β-Lg micro-
structures enhanced quercetin bioaccessibility (Fig. 5B) to 11.8 ± 1.0
% (p ≤ 0.05), which is in agreement with previous studies on protein as
a promising vehicle for hydrophobic compounds (Chen, Li, & Tang,
2015). This result may be attributed to the β-Lg microstructures capa-
city to protect quercetin from the aqueous environment. Also, this
suggests that after hydrolysis of β-Lg microstructures under simulated
intestinal phase conditions, the presence of digestion products (i.e.,
mixed micelles) formed by bile salts and bile acids allowed solubilizing
free fatty acids, monoacylglycerols and some bioactive compounds
(Pinheiro, Coimbra, & Vicente, 2016).
According to the literature, the term “bioavailability” is related to
the amount of the compound ingested, which is absorbed and reaches
the systemic circulation to exert its physiological functions (Gonçalves
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Fig. 4. Intact (%) free riboflavin, β-Lg/riboflavin micro- and nanostructures A)
and free quercetin and β-Lg/quercetin microstructures B) in oral, gastric and
intestinal phases during in vitro digestion. Results were present as mean ±
standard deviation. a,b,c Different small letter superscripts in the same in vitro
digestion phase correspond to statistically significantly differences (p ≤ 0.05).
ND means that the concentration of quercetin was Not Detected.
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riboflavin and quercetin absorption studies (i.e., transport using Caco-2
cell monolayer), the term “bioavailability potential” was used. Com-
paring with the riboflavin in free form, β-Lg micro- and nanostructures
were capable to enhance riboflavin bioavailability potential (p ≤ 0.05)
(Fig. 5A). Bourbon et al. (2018) observed a similar behaviour when
using a dynamic in vitro GI model to determine the bioavailable fraction
of caffeine (as hydrophilic model compound) using Lf-GMP nanohy-
drogels with chitosan coating as the encapsulation matrix. The authors
obtained a caffeine bioavailability of 63.1 ± 0.2 % when caffeine was
associated to nanohydrogels and of 59.2 ± 2.1 % when caffeine is
present in its free form. Riboflavin bioavailability potential (Fig. 5A)
significantly increased (p ≤ 0.05) when the particle size decreased,
being 60.0 ± 0.4 % for β-Lg micro-structures and 73.2 ± 5.5 % for β-
Lg nanostructures. Indeed, the reduced size of β-Lg nanostructures may
has higher potential to improve the solubility, and bioavailability po-
tential, in preventing undesirable physical and chemical reactions, as
well as in protecting bioactive compounds against degradation
(Samadarsi & Dutta, 2019).
As shown in Fig. 5B, β-Lg/quercetin microstructures demonstrated a
prominent enhancement of quercetin absorption, leading to an increase
of bioavailability potential 5.0 ± 0.5 %, when compared to quercetin
in free form. Diarrassouba et al. (2015) evaluated β-Lg-based coagulum
matrix as oral delivery system for of vitamin D3 and obtained an en-
hanced bioactive compound bioavailability determined by rat plasma
analysis.
After assessing the bioactive compounds concentration which
reached intestinal phase (Fig. 4), bioaccessible and bioavailable po-
tential fraction of model bioactive compounds (Fig. 5), it was possible
to determine the effective riboflavin and quercetin concentrations that
might be potentially absorbed. First, we considered our previous asso-
ciation efficiency (AE) results (Simões, Abrunhosa, et al., 2020), where
we evaluated the bioactive compound fraction successfully entrapped
within structures. The initial riboflavin concentration used was
0.105 mg mL−1, which led to a maximum association efficiency (AE) of
64.4 % for both β-Lg micro- and nanostructures. After determining the
hydrophilic bioactive compound concentration in intestinal phase and
riboflavin bioaccessibility and bioavailability potential (Fig. 5A), β-Lg/
riboflavin microstructures were able to maintain 21.6 × 10−3 mg
mL−1 of riboflavin, while β-Lg/riboflavin nanostructures were capable
to retain 31.0 × 10−3 mg mL−1 of riboflavin. Based on Caco-2 cell
viability results of β-Lg/riboflavin micro- and nanostructures,
21 × 10−3 mg mL−1 of riboflavin was non-cytotoxic to Caco-2 cells.
Thus, the riboflavin fraction that remained potentially bioavailable in
this study indicated that β-Lg/riboflavin micro- and nanostructures
could be eventually cytotoxic to Caco-2 cells. However, the potential
bioavailability value was calculated based in an empirical model that
do not consider an extensive bioactive compound metabolic conversion
related with GI digestion. Overall, the bioavailability is influence by
several physical and chemical characteristics, for instance, the con-
centration of bioactive compound that reached intestinal without che-
mical transformations; the bioactive compound fraction not metabo-
lized by the gut and; the bioactive compound transport coefficient and
permeability (Ting, Jiang, Ho, & Huang, 2014). Therefore, bioavail-
ability is a complex parameter and more studies would be needed to
determined its real value.
Regarding quercetin, the initial concentration used was
0.08 mg mL−1 and β-Lg/quercetin microstructures revealed 98.0 % of
AE (Simões, Abrunhosa, et al., 2020). Based on results presented in
Fig. 5B, it was assessed that β-Lg/quercetin micro-structures were able
to maintain 0.46 × 10−3 mg mL−1 quercetin potential bioavailable
after simulated GI tract. Based on Caco-2 cell viability results of β-Lg/
quercetin microstructures, 16 × 10−3 mg mL−1 quercetin maintained
100 % of cell viability. Therefore, since this structure remained po-
tential bioavailable at 0.35 × 10−3 mg mL−1 of quercetin, this is an
indication that the β-Lg/quercetin microstructures produced could be
used without potential risk to cells.
4. Conclusions
The cell viability assay reported herein have demonstrated that the
concentration of β-Lg/quercetin microstructures (i.e., before in vitro
digestion) were non-toxic to Caco-2 cells.
In vitro GI digestion results demonstrated that β-Lg micro- and na-
nostructures were effective in protecting both hydrophilic and hydro-
phobic bioactive compounds during the gastric phase, thus releasing
them in the desirable target site (i.e., intestine), where β-Lg structures
were completely hydrolysed. Moreover, the in vitro digestion results
indicated an improvement of both bioactive compounds fractions
bioavailability potential on β-Lg/riboflavin micro- and nanostructures,
and on β-Lg/quercetin microstructures when compared to the re-
spective compound in its free form.
Our work results contributed to the improvement of the knowledge
regarding the use of β-Lg micro- and nanostructures as an effective oral
delivery system strategy to augment the hydrophilic and hydrophobic
bioactive compounds’ bioavailability potential. However, further stu-
dies will be needed to fully understand the behaviour of β-Lg micro-
and nanostructures during digestion for example, using a dynamic GI
model that mimics the GI peristaltic movements. Also, it would be
important to assess the permeability and absorption rates of both
bioactive model compounds across Caco-2/HT-29 cells, once this other
system allows simulating the production of mucus on the epithelium,
thus mimicking more closely its properties.
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